Second International Symposium

Novel Agents against Infectious Diseases - An Interdisciplinary Approach

Würzburg, October 7 - 10, 2009

Location

Biocenter
Lecture Hall A101

Am Hubland
97074 Würzburg

Program

Wednesday, October, 7

17:00 - 18.30                Registration

18.30 - 19.30                Public keynote talk
                           Reto Brun, Swiss Tropical Institute, Basel
                           Parasitic diseases - Current situation and new developments

19.30 - 21:00                Come together

Thursday, October, 8

9.00 – 9.15                   Welcome
Alfred Forchel, President of the University of Würzburg
Gerhard Bringmann, Speaker of the SFB 630

Medicinal Chemistry

9.15 - 10.00                  Serge Van Calenbergh, Gent
Synthetic efforts to improve the antimalarial activity of fosmidomycin
10.00 - 10.45                Roderich Süssmuth, Berlin
Screening for new natural products - what we learn from nature!

10.45 – 11.15               Coffee break

The nature of drugs
11.15 - 12.00               Julian Davies, Vancouver
The Chemical Biology of Antibiotics
Jordi Mestres, Barcelona
Drug pharmacology in complex diseases

12.45 – 14.15               Lunch

 Microbiology
14.15 - 14.45                Michael Steinert, Braunschweig
New drug targets in Legionella pneumophila
14.45 - 15.15                Wilma Ziebuhr, Belfast
Biofilm-forming Staphylococcus epidermidis: Clinical Impact, Molecular Epidemiology  and Genome Flexibility
15.15 - 15.45                Peter Staib, Jena
Identification and analysis of pathogenicity mechanisms in dermatophytes

15.45 – 16.15               Coffee Break

Bioinformatics / Computer Aided Drug Design
16.15 - 17.00                Holger Gohlke, Düsseldorf
Selectivity determinants of ribosomal antibiotic binding sites
17.00 - 17.45                Roderick Hubbard, York
Recent Experiences in Fragment and Structure Based Drug Discovery

18.00                              Poster Session

Friday, October, 9

Novel Strategies towards drug discovery
9.00 - 9.45                    Heike Brötz-Oesterhelt, Wuppertal
Postgenomic strategies towards novel antibacterial agents
9.45 - 10.30                  Ian Gilbert, Dundee
Approaches to Drug Discovery for Neglected Tropical Diseases 


10.30 – 11.00               Coffee Break

Parasitology
11.00 - 11.45                Katja Becker, Gießen
Redox-based antimalarial drug development – an update
11.45 - 12.15                Gabriele Pradel, Würzburg
Molecular basics for malaria transmission blocking strategies
12.15 - 12.45                Alicia Ponte-Sucre, Caracas
Leishmaniasis, efforts for an effective chemotherapy

12.45 – 14.15               Lunch

13.00 - 14.15                "Plan Your Career" Luncheon:
PhD-Thesis - and then?
Lunch-Meeting for Students, PostDocs and Young Investigators
organized by SFB630 and Graduate School of Life Science, University Würzburg

14.15 – 15.00               Oral Poster Presentations

Viral targets / Proteinases
15.00 - 15.45                Hans-Georg Kräusslich, Heidelberg
HIV assembly and its inhibition
15.45 - 16.30                Rolf Hilgenfeld, Lübeck
Cysteine proteases from RNA viruses and protozoa: Structure-assisted discovery of new antiinfectives

16.30 – 17.00               Coffee Break

 Proteinases
17.00 - 17.45                Michael Blackman, London
Protease drug targets in host cell invasion and egress by the malaria parasite

18.00                              Guided tours
19.30                              Dinner

Saturday, October, 10, 2009

 Natural drug sources
9.00 - 9.45                     Gabriele König, Bonn
Novel bacterial sources for antibiotics
9.45 - 10.30                  Elke Dittmann, Berlin
Biosynthetic Repertoire in Cyanobacterial Peptide Assembly - A Biotechnological Perspective

10.30 – 11.00               Coffee Break

 Pathogen prophylaxis, detection and treatment
11.00 - 11.30               Jürgen Popp, Jena
Pathogen dectection and identification by spectroscopic methods
11.30 - 12.15                Wolf D. Splettstößer, München
Bioterrorism and infectious diseases related to BW agents: Currents concepts & future trends in prophylaxis and treatment

12.15                              Closing Remarks